Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchaltranslucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population
P. Schwarzler et al., Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchaltranslucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population, BR J OBST G, 106(10), 1999, pp. 1029-1034
Objectives To evaluate first trimester pregnancy screening for fetal aneupl
oidy and congenital heart defects by maternal age and nuchal translucency m
easurement and screening for fetal aneuploidies and congenital heart defect
s by ultrasound in an unselected population.
Design A prospective study.
Setting Fetal medicine unit, St George's Hospital, London.
Sample 4523 consecutive viable fetuses at 10-14 weeks with a crown-rump len
gth between 38 and 80 mm were scanned transabdominally (93%) or transvagina
lly (7%).
Methods Screening was performed by calculating the background risk from mat
ernal age, gestational age and obstetric history, which was then adjusted w
ith the nuchal translucency measurement in relation to crown-rump length (a
djusted risk).
Main outcome measures Measurements of crown-rump length and nuchal transluc
ency thickness. An adjusted risk of > 1:270 was considered as a positive sc
reening test. Pregnancy outcome was obtained through karyotyping, outcome q
uestionnaires and examination of the newborn infants.
Results Mean maternal age was 29.4 years and mean gestational age 12.2 week
s. Screening was positive in 230/4523 fetuses (5.1%), when the adjusted ris
k (mean 1:2649) was > 1:270, Fetal karyotype was abnormal in 23 (0.51%) cas
es, including twelve with trisomy 21, five trisomy 18, one trisomy 13, one
trisomy 10, one monosomy X and two triploidies. For a false positive rate o
f 4.7%, the sensitivity of this test was 78% in detecting any fetal aneuplo
idy. Only one out of nine major congenital heart defects in this population
was found within the 110 euploid fetuses with increased nuchal translucenc
y thickness (> 2.5 mm).
Conclusion Screening for fetal aneuploidy by maternal age and nuchal transl
ucency measurement can be effective in an unselected population. However, o
ur results do not support its effectiveness in the detection of cardiac abn
ormalities.